Comparer des méthodes

	Score CHA₂DS₂-VASc	Score de sévérité de la pneumonie CURB-65	Score qSOFA
Domaine	Évaluation clinique	Évaluation clinique	Évaluation clinique
Famille	Process / pipeline	Process / pipeline	Process / pipeline
Année d'origine	2010	2003	2016
Auteur d'origine	Gregory Y. H. Lip, Robby Nieuwlaat, et al.	W. Staniford Lim, et al.	Sepsis-3 Taskforce
Type	Atrial fibrillation stroke risk stratification	Community-acquired pneumonia severity assessment	Rapid sepsis screening
Source fondatrice	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Alias	CHA2DS2VASc, Atrial fibrillation stroke risk	CURB-65, Pneumonia severity	Quick SOFA, qSOFA
Apparentées	3	3	3
Résumé	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.